SM
GILD icon

Senvest Management’s Gilead Sciences GILD Stock Holding History

Senvest Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-70,000
Closed -$4.96M – 46
2018
Q2 		$4.96M Buy
+70,000
New +$4.94M 0.34% 42
2018
Q1 		– Sell
-187,597
Closed -$13.4M – 58
2017
Q4 		$13.4M Sell
187,597
-269,548
-59% -$20.5M 0.95% 31
2017
Q3 		$37M Buy
457,145
+219,520
+92% +$16.8M 2.44% 11
2017
Q2 		$16.8M Buy
+237,625
New +$15.8M 1.32% 24

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Senvest Management's GILD Position: Q3 2018 in Review

Senvest Management sold out of Gilead Sciences (GILD) in Q3 2018, closing a stake of 70,000 shares — an estimated $4.96M sold.

Senvest Management first reported a position in GILD in Q2 2017 and held it in 4 quarters. The position peaked at $37M in Q3 2017. 1,528 funds tracked by Wall St. Rank hold GILD as of Q3 2018.

  • Senvest Management reported no remaining Gilead Sciences position as of Q3 2018 after selling out during the quarter.
  • Senvest Management sold 70,000 Gilead Sciences shares in Q3 2018, an estimated $4.96M.
  • Senvest Management first reported a position in Gilead Sciences in Q2 2017 and held it in 4 quarters.
  • Senvest Management's Gilead Sciences position peaked at $37M in Q3 2017.
  • 1,528 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2018.

Based on Senvest Management's 13F filing for Q3 2018, filed 13 Nov 2018.